95 Lorlatinib in advanced ALK-rearranged NSCLC – real-world experience in a UK population

Saved in:
Bibliographic Details
Published in:Lung cancer (Amsterdam, Netherlands) Netherlands), 2024-04, Vol.190, p.107656, Article 107656
Main Authors: Lucas, Tylan, Hassan, Heba, Sattar, Alisha, So, Alfred, Buckley, Thomas, Hunter, Sarah, Masento, Sebastian, Naureen, Sofia, Benafif, Sarah, Boleti, Ekaterina, Tarver, Kathryn, Ahmad, Tanya, Newsom-Davis, Tom, Janusweski, Adam, Shah, Riyaz, Ghosh, Sharmistha, Daniel Johnathan, Hughes
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page
container_issue
container_start_page 107656
container_title Lung cancer (Amsterdam, Netherlands)
container_volume 190
creator Lucas, Tylan
Hassan, Heba
Sattar, Alisha
So, Alfred
Buckley, Thomas
Hunter, Sarah
Masento, Sebastian
Naureen, Sofia
Benafif, Sarah
Boleti, Ekaterina
Tarver, Kathryn
Ahmad, Tanya
Newsom-Davis, Tom
Janusweski, Adam
Shah, Riyaz
Ghosh, Sharmistha
Daniel Johnathan, Hughes
description
doi_str_mv 10.1016/j.lungcan.2024.107656
format article
fullrecord <record><control><sourceid>elsevier_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1016_j_lungcan_2024_107656</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0169500224002010</els_id><sourcerecordid>S0169500224002010</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1026-df9f6723f31ce98c8137af1b6392d5a1e1e696661724bf89d94b47d2b49be01f3</originalsourceid><addsrcrecordid>eNqFkE1OwzAQhS0EEqVwBCRfIMXjJE68QlUEFDWCBXTFwnL8U7kKTuS0BXbcgRtyEtyfPavRPL33NPMhdA1kAgTYzWrSbvxSST-hhGZRK1jOTtAIyoImZZrSUzSKPp7khNBzdDEMK0KgAMJH6I3nuO5CK9fOuwY7j6XeSq-MxtN6ngQjQ5B-Gdenl6qu8O_3D45im3zEkMbmszfBmejfR_Fijvuu3-zqOn-JzqxsB3N1nGO0uL97rWZJ_fzwWE3rRAGhLNGWW1bQ1KagDC9VCWkhLTQs5VTnEgwYxhljUNCssSXXPGuyQtMm440hYNMxyg-9KnTDEIwVfXDvMnwJIGJHSKzEkZDYERIHQjF3e8iZeNzWmSAGtf9Fu2DUWujO_dPwB5oJcYI</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>95 Lorlatinib in advanced ALK-rearranged NSCLC – real-world experience in a UK population</title><source>ScienceDirect Journals</source><creator>Lucas, Tylan ; Hassan, Heba ; Sattar, Alisha ; So, Alfred ; Buckley, Thomas ; Hunter, Sarah ; Masento, Sebastian ; Naureen, Sofia ; Benafif, Sarah ; Boleti, Ekaterina ; Tarver, Kathryn ; Ahmad, Tanya ; Newsom-Davis, Tom ; Janusweski, Adam ; Shah, Riyaz ; Ghosh, Sharmistha ; Daniel Johnathan, Hughes</creator><creatorcontrib>Lucas, Tylan ; Hassan, Heba ; Sattar, Alisha ; So, Alfred ; Buckley, Thomas ; Hunter, Sarah ; Masento, Sebastian ; Naureen, Sofia ; Benafif, Sarah ; Boleti, Ekaterina ; Tarver, Kathryn ; Ahmad, Tanya ; Newsom-Davis, Tom ; Janusweski, Adam ; Shah, Riyaz ; Ghosh, Sharmistha ; Daniel Johnathan, Hughes</creatorcontrib><identifier>ISSN: 0169-5002</identifier><identifier>EISSN: 1872-8332</identifier><identifier>DOI: 10.1016/j.lungcan.2024.107656</identifier><language>eng</language><publisher>Elsevier B.V</publisher><ispartof>Lung cancer (Amsterdam, Netherlands), 2024-04, Vol.190, p.107656, Article 107656</ispartof><rights>2024 Elsevier B.V.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Lucas, Tylan</creatorcontrib><creatorcontrib>Hassan, Heba</creatorcontrib><creatorcontrib>Sattar, Alisha</creatorcontrib><creatorcontrib>So, Alfred</creatorcontrib><creatorcontrib>Buckley, Thomas</creatorcontrib><creatorcontrib>Hunter, Sarah</creatorcontrib><creatorcontrib>Masento, Sebastian</creatorcontrib><creatorcontrib>Naureen, Sofia</creatorcontrib><creatorcontrib>Benafif, Sarah</creatorcontrib><creatorcontrib>Boleti, Ekaterina</creatorcontrib><creatorcontrib>Tarver, Kathryn</creatorcontrib><creatorcontrib>Ahmad, Tanya</creatorcontrib><creatorcontrib>Newsom-Davis, Tom</creatorcontrib><creatorcontrib>Janusweski, Adam</creatorcontrib><creatorcontrib>Shah, Riyaz</creatorcontrib><creatorcontrib>Ghosh, Sharmistha</creatorcontrib><creatorcontrib>Daniel Johnathan, Hughes</creatorcontrib><title>95 Lorlatinib in advanced ALK-rearranged NSCLC – real-world experience in a UK population</title><title>Lung cancer (Amsterdam, Netherlands)</title><issn>0169-5002</issn><issn>1872-8332</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNqFkE1OwzAQhS0EEqVwBCRfIMXjJE68QlUEFDWCBXTFwnL8U7kKTuS0BXbcgRtyEtyfPavRPL33NPMhdA1kAgTYzWrSbvxSST-hhGZRK1jOTtAIyoImZZrSUzSKPp7khNBzdDEMK0KgAMJH6I3nuO5CK9fOuwY7j6XeSq-MxtN6ngQjQ5B-Gdenl6qu8O_3D45im3zEkMbmszfBmejfR_Fijvuu3-zqOn-JzqxsB3N1nGO0uL97rWZJ_fzwWE3rRAGhLNGWW1bQ1KagDC9VCWkhLTQs5VTnEgwYxhljUNCssSXXPGuyQtMm440hYNMxyg-9KnTDEIwVfXDvMnwJIGJHSKzEkZDYERIHQjF3e8iZeNzWmSAGtf9Fu2DUWujO_dPwB5oJcYI</recordid><startdate>202404</startdate><enddate>202404</enddate><creator>Lucas, Tylan</creator><creator>Hassan, Heba</creator><creator>Sattar, Alisha</creator><creator>So, Alfred</creator><creator>Buckley, Thomas</creator><creator>Hunter, Sarah</creator><creator>Masento, Sebastian</creator><creator>Naureen, Sofia</creator><creator>Benafif, Sarah</creator><creator>Boleti, Ekaterina</creator><creator>Tarver, Kathryn</creator><creator>Ahmad, Tanya</creator><creator>Newsom-Davis, Tom</creator><creator>Janusweski, Adam</creator><creator>Shah, Riyaz</creator><creator>Ghosh, Sharmistha</creator><creator>Daniel Johnathan, Hughes</creator><general>Elsevier B.V</general><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>202404</creationdate><title>95 Lorlatinib in advanced ALK-rearranged NSCLC – real-world experience in a UK population</title><author>Lucas, Tylan ; Hassan, Heba ; Sattar, Alisha ; So, Alfred ; Buckley, Thomas ; Hunter, Sarah ; Masento, Sebastian ; Naureen, Sofia ; Benafif, Sarah ; Boleti, Ekaterina ; Tarver, Kathryn ; Ahmad, Tanya ; Newsom-Davis, Tom ; Janusweski, Adam ; Shah, Riyaz ; Ghosh, Sharmistha ; Daniel Johnathan, Hughes</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1026-df9f6723f31ce98c8137af1b6392d5a1e1e696661724bf89d94b47d2b49be01f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lucas, Tylan</creatorcontrib><creatorcontrib>Hassan, Heba</creatorcontrib><creatorcontrib>Sattar, Alisha</creatorcontrib><creatorcontrib>So, Alfred</creatorcontrib><creatorcontrib>Buckley, Thomas</creatorcontrib><creatorcontrib>Hunter, Sarah</creatorcontrib><creatorcontrib>Masento, Sebastian</creatorcontrib><creatorcontrib>Naureen, Sofia</creatorcontrib><creatorcontrib>Benafif, Sarah</creatorcontrib><creatorcontrib>Boleti, Ekaterina</creatorcontrib><creatorcontrib>Tarver, Kathryn</creatorcontrib><creatorcontrib>Ahmad, Tanya</creatorcontrib><creatorcontrib>Newsom-Davis, Tom</creatorcontrib><creatorcontrib>Janusweski, Adam</creatorcontrib><creatorcontrib>Shah, Riyaz</creatorcontrib><creatorcontrib>Ghosh, Sharmistha</creatorcontrib><creatorcontrib>Daniel Johnathan, Hughes</creatorcontrib><collection>CrossRef</collection><jtitle>Lung cancer (Amsterdam, Netherlands)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lucas, Tylan</au><au>Hassan, Heba</au><au>Sattar, Alisha</au><au>So, Alfred</au><au>Buckley, Thomas</au><au>Hunter, Sarah</au><au>Masento, Sebastian</au><au>Naureen, Sofia</au><au>Benafif, Sarah</au><au>Boleti, Ekaterina</au><au>Tarver, Kathryn</au><au>Ahmad, Tanya</au><au>Newsom-Davis, Tom</au><au>Janusweski, Adam</au><au>Shah, Riyaz</au><au>Ghosh, Sharmistha</au><au>Daniel Johnathan, Hughes</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>95 Lorlatinib in advanced ALK-rearranged NSCLC – real-world experience in a UK population</atitle><jtitle>Lung cancer (Amsterdam, Netherlands)</jtitle><date>2024-04</date><risdate>2024</risdate><volume>190</volume><spage>107656</spage><pages>107656-</pages><artnum>107656</artnum><issn>0169-5002</issn><eissn>1872-8332</eissn><pub>Elsevier B.V</pub><doi>10.1016/j.lungcan.2024.107656</doi></addata></record>
fulltext fulltext
identifier ISSN: 0169-5002
ispartof Lung cancer (Amsterdam, Netherlands), 2024-04, Vol.190, p.107656, Article 107656
issn 0169-5002
1872-8332
language eng
recordid cdi_crossref_primary_10_1016_j_lungcan_2024_107656
source ScienceDirect Journals
title 95 Lorlatinib in advanced ALK-rearranged NSCLC – real-world experience in a UK population
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-23T23%3A50%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-elsevier_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=95%20Lorlatinib%20in%20advanced%20ALK-rearranged%20NSCLC%20%E2%80%93%20real-world%20experience%20in%20a%20UK%20population&rft.jtitle=Lung%20cancer%20(Amsterdam,%20Netherlands)&rft.au=Lucas,%20Tylan&rft.date=2024-04&rft.volume=190&rft.spage=107656&rft.pages=107656-&rft.artnum=107656&rft.issn=0169-5002&rft.eissn=1872-8332&rft_id=info:doi/10.1016/j.lungcan.2024.107656&rft_dat=%3Celsevier_cross%3ES0169500224002010%3C/elsevier_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c1026-df9f6723f31ce98c8137af1b6392d5a1e1e696661724bf89d94b47d2b49be01f3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true